Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

MLA

Sos, Martin L., et al. “Predicting Drug Susceptibility of Non-Small Cell Lung Cancers Based on Genetic Lesions.” The Journal of Clinical Investigation, vol. 119, no. 6, June 2009, pp. 1727–40. EBSCOhost, https://doi.org/10.1172/JCI37127.

APA

Sos, M. L., Michel, K., Zander, T., Weiss, J., Frommolt, P., Peifer, M., Li, D., Ullrich, R., Koker, M., Fischer, F., Shimamura, T., Rauh, D., Mermel, C., Fischer, S., Stückrath, I., Heynck, S., Beroukhim, R., Lin, W., Winckler, W., … Thomas, R. K. (2009). Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. The Journal of Clinical Investigation, 119(6), 1727–1740. https://doi.org/10.1172/JCI37127

Chicago

Sos, Martin L, Kathrin Michel, Thomas Zander, Jonathan Weiss, Peter Frommolt, Martin Peifer, Danan Li, et al. 2009. “Predicting Drug Susceptibility of Non-Small Cell Lung Cancers Based on Genetic Lesions.” The Journal of Clinical Investigation 119 (6): 1727–40. doi:10.1172/JCI37127.